Cargando…
Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
Pancreatic ductal adenocarcinoma (PDAC) is rapidly becoming one of the leading causes of cancer-related deaths in the United States, and with its high mortality rate, there is a pressing need to develop sensitive and robust methods for detection. Exosomal biomarker panels provide a promising avenue...
Autores principales: | Makler, Amy, Asghar, Waseem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049393/ https://www.ncbi.nlm.nih.gov/pubmed/36982154 http://dx.doi.org/10.3390/ijms24065081 |
Ejemplares similares
-
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
por: Makler, Amy, et al.
Publicado: (2022) -
Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021) -
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021) -
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020) -
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017)